Siren
PrivateLast Round
Strategic
Jan 8, 2025
Total Funding Raised
$40.2M
Company Overview
Siren operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Strategic round in January 2025.
Siren is a healthcare technology company that develops smart textiles and remote patient monitoring solutions, including temperature-sensing socks designed to prevent diabetic foot ulcers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Telemedicine, Sensors
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Siren Comparables
Compare Siren with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Empo Health | 85% | |
| Orpyx Medical Technologies | 85% | |
| Sensoria Health | 84% |
For institutional investors. Book with your work email.
Siren Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 8, 2025 | ||||
| Series B Extension | Sep 30, 2020 | ||||
| Series B | May 27, 2020 | ||||
| Series A | Aug 1, 2018 | ||||
| Seed | Mar 28, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Siren Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Seed |
| A-Level Capital | Seed |
| Khosla Ventures | Seed, Series B, Series B Extension |
| Gaingels | Series B |
| 500 Global | Seed, Series B, Series B Extension |
| Portfolia | Series B, Series B Extension |
| Founders Fund | Series B, Series B Extension, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2025
$10M raised from Mölnlycke Health Care and Wound Care Global Holdings.
- Sep 30, 2020
$9M round led by Manta Ray Ventures and Mighty Capital.
For institutional investors. Book with your work email.
Siren Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Siren's valuation, stock price, and market status.
Is Siren a public or private company?
Siren is a private company.
What is the current stock price of Siren?
Siren is a private company, so its shares have no public market price. Caplight tracks Siren's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Siren worth (valuation)?
Valuation information for Siren is not publicly available.
Can I buy Siren stock?
Siren shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Siren's last funding round?
Siren's most recent funding round was Strategic on January 8, 2025.
Who are the main investors in Siren?
Key investors in Siren include Founders Fund, DCM Ventures, Mighty Capital, Aloft VC, Manta Ray Ventures.
Will Siren IPO soon?
No public IPO plans have been announced for Siren.
How can I track Siren secondary market activity?
Caplight tracks bids, offers, and trades in Siren's shares on secondary markets.